130 related articles for article (PubMed ID: 34107240)
1. The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis.
Yang H; Chen Q; Huang A; Yu X; Chen G; Hu X; Wang W; Liu H; Zhang X; Liu L
J Pharm Pharm Sci; 2021; 24():292-307. PubMed ID: 34107240
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.
Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S
Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822
[TBL] [Abstract][Full Text] [Related]
3. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia in pediatric renal transplant recipients.
Uslu Gokceoglu A; Akman S; Koyun M; Comak E; Dogan CS; Akbas H; Dinckan A
Exp Clin Transplant; 2013 Dec; 11(6):489-93. PubMed ID: 24344940
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant Hyperuricemıa as a Cardıovascular Risk Factor.
Erkmen Uyar M; Sezer S; Bal Z; Guliyev O; Tutal E; Kulah E; Genctoy G; Ozdemir Acar N; Haberal M
Transplant Proc; 2015 May; 47(4):1146-51. PubMed ID: 26036541
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and potential relevance of hyperuricemia in pediatric kidney transplant recipients-a CERTAIN registry analysis.
Ehren R; Habbig S; Krupka K; Ernst A; Bald M; König S; Murer L; Özçakar ZB; Pohl M; Babenko N; Spartà G; Staude H; Dello Strologo L; Szabó AJ; Tönshoff B; Weber LT
Pediatr Transplant; 2022 Jun; 26(4):e14265. PubMed ID: 35263498
[TBL] [Abstract][Full Text] [Related]
7. Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.
Han M; Lee JP; Park S; Kim Y; Kim YC; Ahn C; Han DJ; Ha J; Jung IM; Lim CS; Kim YS; Kim YH; Oh YK
PLoS One; 2017; 12(5):e0176786. PubMed ID: 28467476
[TBL] [Abstract][Full Text] [Related]
8. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy and safety between febuxostat and allopurinol in early post-renal transplant recipients with new onset of hyperuricemia.
Shen X; Li J; Fu Q; Liu L; Gao X; Chen X; Chen P; Wang C
J Clin Pharm Ther; 2019 Apr; 44(2):318-326. PubMed ID: 30582178
[TBL] [Abstract][Full Text] [Related]
10. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
[TBL] [Abstract][Full Text] [Related]
12. The association between serum uric acid levels at 3 months after renal transplantation and the graft outcome in living donor renal transplantation.
Choi JY; Kwon OJ
Transplant Proc; 2013 May; 45(4):1548-52. PubMed ID: 23726617
[TBL] [Abstract][Full Text] [Related]
13. Kidney Transplantation From Old Deceased Donors: Impact of Uric Acid Level-A Quarter-Century of Experience in One Transplant Center.
Magott-Procelewska M; Madziarska K; Boratynska M; Chudoba P; Lepiesza A; Mazanowska O; Zmonarski S; Madziarski M; Hap K; Klinger M
Transplant Proc; 2018; 50(6):1701-1704. PubMed ID: 30056885
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
Akalin E; Ganeshan SV; Winston J; Muntner P
Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.
Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838
[TBL] [Abstract][Full Text] [Related]
16. Effects of hyperuricemia on renal function of renal transplant recipients: a systematic review and meta-analysis of cohort studies.
Huang Y; Li YL; Huang H; Wang L; Yuan WM; Li J
PLoS One; 2012; 7(6):e39457. PubMed ID: 22745759
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of febuxostat for treatment of asymptomatic hyperuricemia among kidney transplant patients: A meta-analysis of observational studies.
Chewcharat A; Chang YT; Thongprayoon C; Crisafio A; Bathini T; Mao MA; Cheungpasitporn W
Clin Transplant; 2020 Apr; 34(4):e13820. PubMed ID: 32034944
[TBL] [Abstract][Full Text] [Related]
18. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients.
Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK
Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717
[TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid levels in kidney transplant recipients: A cause for concern? A review of recent literature.
Imasuen UJ; Swanson KJ; Parajuli S
Transplant Rev (Orlando); 2023 Jul; 37(3):100775. PubMed ID: 37437509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
